Biotech Volatile Stocks: Lexicon Pharmaceuticals (NASDAQ:LXRX), Corcept Therapeutics Incorporated (NASDAQ:CORT), Insys Therapeutics (NASDAQ:INSY), ANI Pharmaceuticals (NASDAQ:ANIP)

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), just announced a positive, top-line result in a Phase 2 clinical trial of their experimental therapy LX4211 in type 1 diabetes. LX4211, an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2, was designed to lower blood glucose levels through two insulin-independent mechanisms of action. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock performance was 5.16% in last session and finished the … Continue reading Biotech Volatile Stocks: Lexicon Pharmaceuticals (NASDAQ:LXRX), Corcept Therapeutics Incorporated (NASDAQ:CORT), Insys Therapeutics (NASDAQ:INSY), ANI Pharmaceuticals (NASDAQ:ANIP)

Fast Moving Stocks : American Capital Agency Corp. (NASDAQ:AGNC), Transocean Ltd. (NYSE:RIG), Universal Technical Institute, Inc. (NYSE:UTI), International Business Machines Corporation (NYSE:IBM), ANI Pharmaceuticals, Inc. (NASDAQ:ANIP),

On Sept. 18, American Capital Agency Corp. (NASDAQ:AGNC) announced that its Board of Directors has declared a cash dividend of $0.65 per share for the third quarter 2014. The dividend is payable on October 27, 2014 to common shareholders of record as of September 30, 2014, with an ex-dividend date of September 26, 2014. American Capital Agency Corp. (NASDAQ:AGNC) belongs to Financial sector. Its weekly … Continue reading Fast Moving Stocks : American Capital Agency Corp. (NASDAQ:AGNC), Transocean Ltd. (NYSE:RIG), Universal Technical Institute, Inc. (NYSE:UTI), International Business Machines Corporation (NYSE:IBM), ANI Pharmaceuticals, Inc. (NASDAQ:ANIP),

Ignyta Inc (NASDAQ:RXDX) released its earnings data. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.37) by $0.09. Finally, analysts at Ladenburg Thalmann initiated coverage on shares of company in a research note on Monday, March 24th. They set a “buy” rating and a $20.00 price target on the stock. Ignyta Inc (NASDAQ:RXDX) stock performance was 13.12% … Continue reading Biotech Gainers: Ignyta Inc (NASDAQ:RXDX), Onconova Therapeutics Inc (NASDAQ:ONTX), Cempra Inc (NASDAQ:CEMP), ANI Pharmaceuticals Inc (NASDAQ:ANIP)